Lucka 15 - vem finns här?

Det lackar mot jul och det vill vi uppmärksamma tillsammans med er. Varje dag fram till jul får vi här veta vad profiler i life science-världen har på sin önskelista.

KI inviger nytt tvärvetenskapligt forskningscentrum

Professor Agneta Richter-Dahlfors blir direktör för Aimes, där fokus ligger på tvärvetenskaplig forskning.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Measure blood sugar without finger pricking

The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a sma...

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Första patienterna har testat kräm för hårväxtstimulering

Nu har Follicums fas II-studie med FOL-005-kräm startat på riktigt. De första manliga patienterna med håravfall har nu behandlats.

Pfizer buys Swiss vaccines

Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.

Showroom for free

The latest equipment with trained staff. Sci Life Lab in Stockholm want to offer top conditions at the new imaging laboratory. But some vendors are skeptical to...

Astra Zeneca lovar leverans av 2 miljarder vaccindoser mot corona

Totalt har läkemedelsföretaget ingått avtal med flera producenter och lovar nu leverans om totalt 2 miljoner vaccindoser mot det nya coronaviruset.

"An open mind is the key to successful meetings"

Meeting in person is irreplaceble when it comes to finding a new partner. Johan Ohlsson at Venture Valuation is happy with his meetings at Biotech Forum so far ...

Missnöjd med din julklappsslips? Här är våra läsetips

Take off for this year's fair

More visitors than previously were preregistered when Scanlab and Biotech Forum opened today. But the future of the exhibitions and their design is uncertain.

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

Discovery of new role for leukemia gene

Martin Bergö and his colleagues have studied two gene variants that often occur in acute leukemias. One gene codes for the protein RAS, which accelerates cell d...

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...

Academia - a strong player on the lab market

While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Changing e-solutions for clinical trials

Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...

Höjer bud på Actelion

Johnson & Johnson diskuterar förvärv av det schweiziska läkemedelsbolaget, och uppges nu ha höjt sitt bud.

Vill sälja USA-verksamheten

Enligt rykten diskuterar Meda en försäljning av sin amerikanska verksamhet.